Eli Lilly on Friday said it is investing another $5.3 billion in a manufacturing plant in Lebanon, Indiana, to boost supply of its highly popular weight loss drug Zepbound, diabetes treatment ...

Eli Lilly and Company LLY announced a significant $4.5 billion investment for the establishment of the Lilly Medicine Foundry in Indiana to advance drug production and innovation.This facility ...

Eli Lilly and Company plans to invest $4.5 billion in a new drug research and development facility in Lebanon, Indiana. The center will be in the LEAP Research and Innovation District, where Lilly ...

Eli Lilly and Company plans to more than double its investment at the LEAP Research and Innovation District in Lebanon, Indiana. The added investment will enhance the company’s capacity to ...

Eli Lilly plans to invest an additional $5.3B to manufacture more of its blockbuster weight-loss and diabetes treatments at its Indiana plant, the pharma giant announced Friday.

(Reuters) - Eli Lilly and Co said on Monday it will invest an additional $1.6 billion at its two new manufacturing sites in Indiana, United States to support the manufacturing of its recently ...

LEBANON, Indiana — Eli Lilly and Company plans to invest an additional $1.6 billion in two new manufacturing sites at the LEAP Lebanon Innovation and Research District in Boone County. That brings the ...

Eli Lilly and Co said on Monday it will invest an additional $1.6 billion at its two new manufacturing sites in Indiana, United States to support the manufacturing of its recently approved cancer ...

Through this new investment, Lilly intends to expand the manufacturing footprint for its injectable medications, ... Eli Lilly to Invest $3B in Wisconsin Plant to Meet Obesity Drug Demand. 3d.

(Reuters) -Eli Lilly plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a Washington press conference on Wednesday, as it grapples with ...